Header Ads

Home > Top Business News- News18.com > Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir

Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir

May 29, 2020
This comes in the backdrop of two Indian pharmaceutical companies -- Cipla and Hetero Labs -- applying to the drug regulator seeking permission to manufacture and sell remdesivir in India.

from Top Business News- News18.com https://ift.tt/3cb6mFS

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )

UK Firms Hail Victory In Battle Over COVID-19 Insurance Claims

London judges have ruled that some of the world's biggest insurers were wrong to reject tens of thousands of claims from small firms bat...

Powered by Blogger.